Skip to content

Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies

Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies (SUSTAIN): A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04291040
Acronym
SUSTAIN
Enrollment
380
Registered
2020-03-02
Start date
2020-07-09
Completion date
2023-01-30
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, Pregnancy, High Risk

Brief summary

The purpose of the study is to evaluate if the implementation of a multimedia based educational tool and regular reminders with shared decision-making will increase the rate of LARC uptake and retention in high risk pregnancy patients within 12 weeks of delivery and to study the rates of retention of LARC at 12 and 24 months and short-interval pregnancy rates.

Detailed description

This study will include 380 women aged 18-50 enrolled between 28 weeks gestation and postpartum day #1 who have a pregnancy that is considered high-risk. After consent, participants will be randomized to either routine care or multimedia based intervention. The intervention will include an investigator created decision aid presented at the time of randomization and reminder texts until 12 weeks postpartum. The primary objective is to evaluate the rate of LARC uptake and retention within 12 weeks of delivery. Secondary objectives include i) the retention of LARC at 12 and 24 months and ii) short-interval pregnancy rates.

Interventions

BEHAVIORALDecision Aid

Following randomization, participants will independently view the multimedia based decision aid on a provided tablet. They will also receive provider counseling. For the remainder of the pregnancy, they will receive a text message with a link to the multimedia based presentation. This will occur every 4 weeks until 12 weeks postpartum.

BEHAVIORALRoutine Care

The control arm will receive routine prenatal care including provider counselling on postpartum contraceptive options.

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Aged 13-50 years old * High risk pregnancy due to either maternal medical conditions or obstetric/neonatal complications

Exclusion criteria

* Planned cesarean hysterectomy * Unable to provide informed consent in either English or Spanish * Unable to provide reliable cell phone access for the study duration * Not willing to provide follow-up for two years

Design outcomes

Primary

MeasureTime frameDescription
Rate of initial LARC utilization12 weeks postpartum (12 weeks)Number of subjects who elect to have LARC procedure between the 2 arms

Secondary

MeasureTime frameDescription
Number of patients who keep the LARC after placement12 months
rates of short interval pregnancy24 monthsNumber of patients who become pregnant after enrollment pregnancy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026